| |
|
|
|
Drug Self-Administration Markets to 2016
Devices, Drugs, Markets, Strategies and
Forecasts
|
Publication: January 2012
Product Code: SFA825R
|
While alternative methods for delivering therapeutics to
patients have had some notable successes, most drugs
continue to be delivered orally. Because they cannot
tolerate the first-pass metabolism of the digestive tract,
the recent escalation in new biological drugs, including
antibodies and recombinant proteins, is placing renewed
emphasis on alternate delivery technologies. Now a number of
factors are converging to create both risk and opportunity
for drug makers and their delivery device partners. These
include new classes of drugs for previously refractory
conditions, the growing trend toward self-administration for
chronic diseases, shifting patient demographics in
industrial countries, caregiver safety legislation, and
continued pressure to control healthcare costs. These
factors are giving rise to a new generation of
sophisticated, application-specific injection, inhalation
and transdermal drug products designed to satisfy caregiver
and patient preferences while addressing managed care
initiatives and the formulation limitations of new classes
of therapeutic drugs. Because of their ability to safely and
reliably satisfy treatment protocols and compliance goals,
non-oral drug delivery products will have a significant
impact on the future of drug self-administration.
|
|
Highlights |
· Provides detailed
analysis of drug self-administration market segments,
market dynamics and market demographics
· Analyzes therapeutic
demand drivers and evaluates commercial drug products in
more than two dozen major self-administration
therapeutic segments
· Analyzes design
factors, material selection issues, technologies and
market development issues for injection devices,
inhalation devices and transdermal drug products
designed for self-administration
· Charts product data,
market share, and forecasts to 2016
· Profiles
self-administration drug product and device
participants, their product development
activities, business strategies, and corporate
alliances and affiliations
|
|
Summary of Contents |
Executive Summary
Drug Market Dynamics
Evolving
Drug Market Factors
Chronic Disease and
Self-administration
Managed Care and Prescribing Trends
Drug Self-Administration Demand Factors
Shifting
Patient Demographics
Biological Drug Proliferating
Delivery Device Technology & Evolving
Drug
Self-Administration Product Segments and Market Drivers
Injectable Drug Self-Administration Products
Market Sector Dynamics
The Shift to Prefilled Devices
Device Selection Factors
Market Segmentation & Cost
Product Features & Ease of Use
Custom Device Designs &
Branding
Prefilled Syringes (PFS)
Glass PFS
Plastic
PFS
Prospects for Autoinjector s
Key PFS Therapeutic
Segments
The PFS Supply Chain
PFS Supplier Profiles
Pen Injectors
Reusable Pens
Disposable Pens
Key Pen
Injector Therapeutic Segments
The Top Ten Pen Injector
Drug Products
Five Segments Driving Pen Injector Growth
Pen Injector Company Profiles
Needle-free Injectors (NFI)
Reusable NFI
Disposable
Competitive NFI Therapeutic
Segments
Needle-free Company Profiles
Inhaled
Drug Self-Administration Products
Market Sector
Dynamics
The Upper Respiratory Market
Established
Therapeutic Targets
Dual Drug Inhalers
The
Systemic/Deep Lung Market
Established Markets
Emerging
Therapies
Inhaler Technology and Market Prospects
Inhaler Product Segments
Dry Powder Inhalers
Device
Design Factors
Powder Technology
Packaging Issues
DPI Device Company Profiles
Metered Dose Inhalers
Basic Designs
Breathe Actuated Designs
MDI Device
Company Profiles
Nebulizers
Established Nebulizer
Therapies
Evolving Nebulizer Technology
Nebulizer
Device Company Profiles
Performance Factors
Bioavailability
Dose Reproducibility
Active Compound
Stability
Transdermal Drug Products
Market
Sector Dynamics
Traditional Patch Markets
Emerging
Markets
Transdermal Patch Market Drivers
Prescription
Patch Design & Technology
Passive Patch Architecture
Passive Transdermal Patch Design
Passive Patch
Construction
Active Transport Patch Technologies
Iontophoresis
Electroporation
Microporation
Mechanical Arrays
Radio Frequency
Thermal/Heat
Ultrasound
Prescription Patch Development Factors
Key
Transdermal Therapeutic Markets
Transdermal Product
Company Profiles
Drug Self-Administration –
Therapeutic Sector Analysis & Forecasts
ADHD
Anticoagulants
Arthritis
Asthma/COPD
Cardiovascular
Contraception
Cystic Fibrosis
Diabetes
Hematopoietics
Hepatitis
Hormone Therapy/Replacement
Multiple Sclerosis
Neurology
Osteoporosis
Pain
Management
Psoriasis
Sexual Health
|
|
|
|
